Phase 4 Cytomegalovirus Clinical Trials
6 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–6 of 6 trials
Recruiting
Phase 4
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Kidney Transplant; ComplicationsCytomegalovirusOrgan Transplant
Camille N. Kotton, MD80 enrolled2 locationsNCT06958796
Recruiting
Phase 4
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
NeutropeniaCytomegalovirus InfectionsInfection in Solid Organ Transplant Recipients+1 more
Tufts Medical Center25 enrolled1 locationNCT05626530
Recruiting
Phase 4
Cytomegalovirus-specific immune monitoring to guide pre-emptive therapy surveillance protocol for prevention of cytomegalovirus infection after renal transplantation.
Cytomegalovirus infection after renal transplantation
associate Prof. Tomas Reischig, M.D., Ph.D.150 enrolled1 locationACTRN12618000913279
Active
Phase 4
OVERT Study: Optimizing Valganciclovir Efficacy in Renal Transplantation
Cytomegalovirus infection after renal transplantation
ass. Prof. Tomas Reischig, M.D., Ph.D.92 enrolled1 locationACTRN12613000554763
Completed
Phase 4
The 2VAL Study: A trial comparing the effect of valacyclovir and valganciclovir prophylaxis against cytomegalovirus (CMV) infection after renal transplantation
Cytomegalovirus infection after renal transplantation
Tomas Reischig, M.D., Ph.D.114 enrolled1 locationACTRN12610000016033
Completed
Phase 4
Preemptive therapy vs valacyclovir prophylaxis for cytomegalovirus (CMV) disease after renal transplantation
Cytomegalovirus disease in renal transplant recipients
Tomas Reischig, M.D., Ph.D.60 enrolled1 locationACTRN12610000015044